By Bloomberg Law |
February 12, 2020
The federal government is hoping to limit the damages it may have to pay to insurers who claim to have lost billions when it ended a program to repay them for lowering certain members’ out of pocket costs.
Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders.
A new personal protective equipment manufacturing company is set to open in Cincinnati next year.